ESC Premium Access

2016 Dyslipidaemias Guidelines in The Netherlands

Event: ESC CONGRESS 2016
Topic: Epidemiology, lipids
Session type: Guidelines in Practice
Date: 30 August 2016
Time: 08:30 - 10:00

Congress Session

7 presentations in this session

Mobile App Interactive Session.

Thumbnail

A 58 year old banker with coronary artery disease who is intolerant to statin therapy - Clinical case 1

Speaker: Doctor R. Kraaijenhagen (Amsterdam, NL)
Thumbnail

A 58 year old banker with coronary artery disease who is intolerant to statin therapy - What do the Guidelines say?

Speaker: Professor F. Visseren (Utrecht, NL)
Thumbnail

A 58 year old banker with coronary artery disease who is intolerant to statin therapy - Take home message

Speaker: Professor R. Peters (Amsterdam, NL)
Thumbnail

A 58 year old lady with coronary artery disease and a fasting triglycerides level of 4,4 mmol/L. - Clinical case

Speaker: Professor J. Jukema (Leiden, NL)
Thumbnail

A 58 year old lady with coronary artery disease and a fasting triglycerides level of 4,4 mmol/L. - What do the Guidelines say?

Speaker: Doctor J. Wittekoek (Utrecht, NL)
Thumbnail

A 58 year old lady with coronary artery disease and a fasting triglycerides level of 4,4 mmol/L. - Take home message

Speaker: Professor E. Stroes (Amsterdam, NL)
Thumbnail

6 speakers from this session

Doctor Roderik Kraaijenhagen

NDDO Institute for Early Diagnostics and Prevention (NIPED), Amsterdam, the Netherlands. , Amsterdam (Netherlands (The))
1 presentation
0 follower

Professor Frank Visseren

University Medical Center Utrecht, Utrecht (Netherlands (The))
8 presentations
3 followers

Professor Ron J G Peters

Academic Medical Centre, Amsterdam (Netherlands (The))
1 presentation
0 follower

Professor J Wouter Jukema

Leiden University Medical Centre, Leiden (Netherlands (The))
16 presentations
0 follower

Doctor Janneke Wittekoek

, Utrecht (Netherlands (The))
1 presentation
0 follower

Professor Erik Stroes

Academic Medical Centre, Amsterdam (Netherlands (The))
24 presentations
0 follower

This platform is supported by

logo Novo Nordisk